Home › Insero Health Completes Phase I Trial Of Novel Therapy In Patients With Drug Resistant Epilepsy
 

Keywords :   


Insero Health Completes Phase I Trial Of Novel Therapy In Patients With Drug Resistant Epilepsy

2013-01-02 02:28:49| drugdiscoveryonline News Articles

Insero Health, Inc., a company developing natural compounds to address unmet medical needs in neurological disorders, today announced that it has completed a Phase Ib trial of its lead compound INS001 in patients with drug-resistant epilepsy

Tags: with health trial drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.11LL
16.11 1.2.3.4.5.6.
16.11KTF 21SVTW
16.11 a
16.11 Lord Finesse From The Crates To The File
16.11AB6IX
16.11TOMIX JR EF63()
16.11
More »